Can fentanyl be given with rasagiline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fentanyl and Rasagiline: Potential Interaction and Management

Fentanyl should not be administered with rasagiline due to the risk of serotonin syndrome, as fentanyl has serotonin reuptake inhibitory activity that can interact with monoamine oxidase inhibitors like rasagiline. 1

Understanding the Interaction

  • Fentanyl has serotonin reuptake inhibitory activity, which increases the risk of serotonin syndrome when given with medications that affect serotonin levels, including monoamine oxidase inhibitors (MAOIs) like rasagiline 1
  • Rasagiline is a selective irreversible inhibitor of monoamine oxidase B (MAO-B) used in Parkinson's disease treatment 2
  • While rasagiline is selective for MAO-B at recommended doses, this selectivity may not be absolute, creating potential for interaction with serotonergic drugs 3

Clinical Implications

  • Serotonin syndrome is a potentially fatal condition characterized by neuroexcitatory symptoms, autonomic dysfunction, and neuromuscular abnormalities 1
  • Unlike with meperidine (which has a documented life-threatening interaction with MAOIs), the specific interaction between fentanyl and rasagiline is less well-documented but still concerning 1
  • The Mayo Clinic Proceedings specifically warns about perioperative risk of serotonin syndrome when using serotonergic opioids (including fentanyl) with MAOIs 1

Alternative Approaches

  • Consider hydromorphone as an alternative opioid analgesic, which does not have significant serotonergic activity 1
  • If opioid analgesia is necessary in a patient taking rasagiline:
    • Use non-serotonergic opioids 1
    • Ensure close monitoring for signs of serotonin syndrome 4
    • Have naloxone readily available for reversal of opioid effects if needed 5

Special Considerations

  • Rasagiline has shown better MAO-B selectivity than older MAOIs like selegiline, which may reduce but not eliminate interaction risk 3
  • A study of rasagiline with the SSRI escitalopram showed good tolerability in healthy volunteers, but this doesn't guarantee safety with fentanyl, which has different pharmacologic properties 6
  • Rasagiline undergoes extensive hepatic metabolism primarily by CYP1A2, which is a different metabolic pathway than fentanyl, potentially reducing but not eliminating interaction risk 2

Monitoring and Management

  • If fentanyl must be used in a patient on rasagiline (which is not recommended):
    • Use the lowest effective dose 1
    • Monitor closely for signs of serotonin syndrome including agitation, hyperthermia, hyperreflexia, and autonomic instability 1
    • Consider temporary discontinuation of rasagiline if possible before fentanyl administration 2
    • Have benzodiazepines available for management of agitation if serotonin syndrome develops 1

Conclusion

Given the potential risk of serotonin syndrome and the availability of safer alternatives, fentanyl should be avoided in patients taking rasagiline. When analgesia is required, non-serotonergic opioids should be selected instead 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapy.

Therapeutics and clinical risk management, 2007

Research

Selegiline and rasagiline: twins or distant cousins?

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2011

Guideline

Dosing Considerations for Fentanyl and Propofol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Lack of clinically significant interactions between concomitantly administered rasagiline and escitalopram.

Progress in neuro-psychopharmacology & biological psychiatry, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.